Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012568585> ?p ?o ?g. }
- W2012568585 endingPage "1864" @default.
- W2012568585 startingPage "1858" @default.
- W2012568585 abstract "In this paper we examined the effect of flumazenil (Ro 15-1788, 10 mg/kg), a benzodiazepine receptor antagonist, on the anticonflict activity of DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (CGP 37849), a competitive N-methyl-D-aspartate (NMDA) receptor antagonist, and 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at glycine(B) receptors, in the Vogel conflict drinking test in rats. The effect of flumazenil on the anxiolytic-like (in the plus-maze test) and the anticonvulsant (in the maximal electroshock-induced seizures) activities of CGP 37849 in rats was also studied. Diazepam was used as a reference drug. CGP 37849 (2. 5-5 mg/kg), ACPC (50-200 mg/kg) and diazepam (2.5-5 mg/kg) significantly and dose-dependently increased the number of shocks accepted during experimental sessions in the conflict drinking test. Flumazenil partly but significantly reduced the anticonflict effect of CGP 37849, and it fully blocked the anticonflict effect of ACPC and diazepam. CGP 37849 (2.5-5 mg/kg) and diazepam (2.5-5 mg/kg) were also active in the plus-maze test, as they significantly increased the percentage of the time spent in and entries into the open arms of the plus-maze, both those effects having been antagonized by flumazenil. Flumazenil alone was inactive in both the conflict drinking and the plus-maze tests. In the maximal electroshock-induced seizures, both CGP 37849 (2.5-5 mg/kg) and diazepam (5-10 mg/kg) produced anticonvulsant effects, of which only that of diazepam was antagonized by flumazenil. The results of the present study showing antagonism of flumazenil towards the anxiolytic-like effects of CGP 37849 and ACPC suggest involvement of benzodiazepine receptors in such an activity of the NMDA and glycine(B) receptor ligands, respectively, which may be due to a possible interaction between NMDA and GABA/benzodiazepine systems. The lack of effect of the benzodiazepine antagonist on the anticonvulsant activity of CGP 37849 indicates that involvement of benzodiazepine receptors in the pharmacological action of the NMDA antagonist is not a general phenomenon." @default.
- W2012568585 created "2016-06-24" @default.
- W2012568585 creator A5013335339 @default.
- W2012568585 creator A5022808795 @default.
- W2012568585 creator A5063136072 @default.
- W2012568585 date "2000-09-01" @default.
- W2012568585 modified "2023-10-14" @default.
- W2012568585 title "The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats" @default.
- W2012568585 cites W1526981538 @default.
- W2012568585 cites W1965013913 @default.
- W2012568585 cites W1970570648 @default.
- W2012568585 cites W1978342290 @default.
- W2012568585 cites W1978346590 @default.
- W2012568585 cites W1979327971 @default.
- W2012568585 cites W1982970696 @default.
- W2012568585 cites W1984202379 @default.
- W2012568585 cites W1992255572 @default.
- W2012568585 cites W2007152625 @default.
- W2012568585 cites W2008374886 @default.
- W2012568585 cites W2010132442 @default.
- W2012568585 cites W2013536843 @default.
- W2012568585 cites W2016636415 @default.
- W2012568585 cites W2023205562 @default.
- W2012568585 cites W2024969311 @default.
- W2012568585 cites W2026501837 @default.
- W2012568585 cites W2029311282 @default.
- W2012568585 cites W2038893879 @default.
- W2012568585 cites W2061054421 @default.
- W2012568585 cites W2065126541 @default.
- W2012568585 cites W2067437263 @default.
- W2012568585 cites W2068082166 @default.
- W2012568585 cites W2073117914 @default.
- W2012568585 cites W2075672970 @default.
- W2012568585 cites W2088050052 @default.
- W2012568585 cites W2092953670 @default.
- W2012568585 cites W2102038131 @default.
- W2012568585 cites W2142324040 @default.
- W2012568585 cites W2143614879 @default.
- W2012568585 cites W2402166690 @default.
- W2012568585 doi "https://doi.org/10.1016/s0028-3908(00)00023-x" @default.
- W2012568585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10884566" @default.
- W2012568585 hasPublicationYear "2000" @default.
- W2012568585 type Work @default.
- W2012568585 sameAs 2012568585 @default.
- W2012568585 citedByCount "36" @default.
- W2012568585 countsByYear W20125685852012 @default.
- W2012568585 countsByYear W20125685852013 @default.
- W2012568585 countsByYear W20125685852016 @default.
- W2012568585 countsByYear W20125685852017 @default.
- W2012568585 countsByYear W20125685852018 @default.
- W2012568585 countsByYear W20125685852020 @default.
- W2012568585 countsByYear W20125685852021 @default.
- W2012568585 crossrefType "journal-article" @default.
- W2012568585 hasAuthorship W2012568585A5013335339 @default.
- W2012568585 hasAuthorship W2012568585A5022808795 @default.
- W2012568585 hasAuthorship W2012568585A5063136072 @default.
- W2012568585 hasConcept C118552586 @default.
- W2012568585 hasConcept C15744967 @default.
- W2012568585 hasConcept C169760540 @default.
- W2012568585 hasConcept C170493617 @default.
- W2012568585 hasConcept C173586616 @default.
- W2012568585 hasConcept C185592680 @default.
- W2012568585 hasConcept C2775858608 @default.
- W2012568585 hasConcept C2776175493 @default.
- W2012568585 hasConcept C2776885963 @default.
- W2012568585 hasConcept C2777765862 @default.
- W2012568585 hasConcept C2778173252 @default.
- W2012568585 hasConcept C2778186239 @default.
- W2012568585 hasConcept C2778409475 @default.
- W2012568585 hasConcept C2778938600 @default.
- W2012568585 hasConcept C55493867 @default.
- W2012568585 hasConcept C558461103 @default.
- W2012568585 hasConcept C58732023 @default.
- W2012568585 hasConcept C71924100 @default.
- W2012568585 hasConcept C98274493 @default.
- W2012568585 hasConceptScore W2012568585C118552586 @default.
- W2012568585 hasConceptScore W2012568585C15744967 @default.
- W2012568585 hasConceptScore W2012568585C169760540 @default.
- W2012568585 hasConceptScore W2012568585C170493617 @default.
- W2012568585 hasConceptScore W2012568585C173586616 @default.
- W2012568585 hasConceptScore W2012568585C185592680 @default.
- W2012568585 hasConceptScore W2012568585C2775858608 @default.
- W2012568585 hasConceptScore W2012568585C2776175493 @default.
- W2012568585 hasConceptScore W2012568585C2776885963 @default.
- W2012568585 hasConceptScore W2012568585C2777765862 @default.
- W2012568585 hasConceptScore W2012568585C2778173252 @default.
- W2012568585 hasConceptScore W2012568585C2778186239 @default.
- W2012568585 hasConceptScore W2012568585C2778409475 @default.
- W2012568585 hasConceptScore W2012568585C2778938600 @default.
- W2012568585 hasConceptScore W2012568585C55493867 @default.
- W2012568585 hasConceptScore W2012568585C558461103 @default.
- W2012568585 hasConceptScore W2012568585C58732023 @default.
- W2012568585 hasConceptScore W2012568585C71924100 @default.
- W2012568585 hasConceptScore W2012568585C98274493 @default.
- W2012568585 hasIssue "10" @default.
- W2012568585 hasLocation W20125685851 @default.
- W2012568585 hasLocation W20125685852 @default.
- W2012568585 hasOpenAccess W2012568585 @default.